Results 221 to 230 of about 644,554 (330)

The potential for biased signalling in the P2Y receptor family of GPCRs

open access: yesBritish Journal of Pharmacology, EarlyView.
The purinergic receptor family is primarily activated by nucleotides, and contains members of both the G protein coupled‐receptor (GPCR) superfamily (P1 and P2Y) and ligand‐gated ion channels (P2X). The P2Y receptors are widely expressed in the human body, and given the ubiquitous nature of nucleotides, purinergic signalling is involved with a plethora
Claudia M. Sisk   +2 more
wiley   +1 more source

Extracellular Adenine Nucleotides Inhibit the Activation of Human CD4+ T Lymphocytes1

open access: yesJournal of Immunology, 2002
X. Duhant   +6 more
semanticscholar   +1 more source

Epigenetic Regulation of G6PD Drives Metabolic Reprogramming in Intrahepatic Cholangiocarcinoma

open access: yesCancer Science, EarlyView.
This study reveals that tumor‐specific enhancers drive G6PD overexpression in intrahepatic cholangiocarcinoma (ICC), thereby enhancing pentose phosphate pathway activity, maintaining redox homeostasis, and promoting cell proliferation and chemoresistance.
Yusuke Nakano   +15 more
wiley   +1 more source

Glutaminase‐1 Mediated Glutaminolysis to Glutathione Synthesis Maintains Redox Homeostasis and Modulates Ferroptosis Sensitivity in Cancer Cells

open access: yesCell Proliferation, EarlyView.
GLS1‐mediated glutaminolysis supports GSH synthesis in cancer cells. GLS1 KO increases ROS, downregulates GPX4, and upregulates GPX1, making cells more sensitive to ferroptosis. Combining GLS1 or GPX1 inhibitors with a GPX4 inhibitor synergistically suppresses cancer growth.
Changsen Bai   +13 more
wiley   +1 more source

Home - About - Disclaimer - Privacy